Final answer:
In acute myelogenous leukemia (AML), the impaired production of erythrocytes is expected due to the overproduction of immature leukocytes in the myeloid line.
Step-by-step explanation:
In acute myelogenous leukemia (AML), a form of cancer, there is an overproduction of young, immature leukocytes. AML primarily affects the myeloid line, which is responsible for the production of erythrocytes (red blood cells).
The impaired production of erythrocytes is expected in AML because the cancerous cells in the bone marrow replace the healthy cells responsible for producing mature red blood cells. As a result, the patient may experience symptoms of anemia, such as fatigue, shortness of breath, and pale skin.